|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005955,
umls-concept:C0006142,
umls-concept:C0011900,
umls-concept:C0038952,
umls-concept:C0205225,
umls-concept:C0205231,
umls-concept:C0242767,
umls-concept:C0332293,
umls-concept:C0741343,
umls-concept:C1186763,
umls-concept:C1328050,
umls-concept:C1516213
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-11-2
|
|
pubmed:abstractText |
To determine the impact of micrometastatic bone marrow cells (MMC) on survival in high-risk primary breast cancer (HRPBC) patients treated with high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BastertGG,
pubmed-author:DiemHH,
pubmed-author:EgererGG,
pubmed-author:HaasRR,
pubmed-author:HenselMM,
pubmed-author:HoA DAD,
pubmed-author:KaulSS,
pubmed-author:LauschnerII,
pubmed-author:RudlowskiCC,
pubmed-author:SchneeweissAA,
pubmed-author:SchuetzFF,
pubmed-author:SinnH-PHP,
pubmed-author:UnnebrinkKK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1627-32
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15520063-Adult,
pubmed-meshheading:15520063-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15520063-Bone Marrow Cells,
pubmed-meshheading:15520063-Bone Marrow Neoplasms,
pubmed-meshheading:15520063-Breast Neoplasms,
pubmed-meshheading:15520063-Dose-Response Relationship, Drug,
pubmed-meshheading:15520063-Female,
pubmed-meshheading:15520063-Flow Cytometry,
pubmed-meshheading:15520063-Humans,
pubmed-meshheading:15520063-Immunohistochemistry,
pubmed-meshheading:15520063-Lymph Nodes,
pubmed-meshheading:15520063-Menopause,
pubmed-meshheading:15520063-Middle Aged,
pubmed-meshheading:15520063-Neoplasm Staging,
pubmed-meshheading:15520063-Prognosis,
pubmed-meshheading:15520063-Stem Cell Transplantation,
pubmed-meshheading:15520063-Survival Analysis,
pubmed-meshheading:15520063-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.
|
|
pubmed:affiliation |
University of Heidelberg, Department of Gynecology and Obstetrics, Heidelberg, Germany. andreas_schneeweiss@med.uni-heidelberg.de
|
|
pubmed:publicationType |
Journal Article
|
